Edward Pershing - CEO, Director at PROVECTUS BIOPHARMACEUTICALS, INC.

Issuer-level insider activity

Role
CEO, Director
Issuer ticker
PVCT on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Edward Pershing since 07 Jun 2025

Reported holdings for Edward Pershing in PROVECTUS BIOPHARMACEUTICALS, INC.

Form 4 holding CEO, Director

PROVECTUS BIOPHARMACEUTICALS, INC.

Security class
8% Unsecured Convertible Promissory Note
Shares / value
$860,000
Estimated value
Report date
05 Jun 2026
Price
Ownership
Direct
Underlying class
Series D-1 Convertible Preferred Stock
Underlying amount

Transaction history for Edward Pershing in PROVECTUS BIOPHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .